CytomX Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CytomX Therapeutics, Inc. (CTMX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 3.44 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 824.50K shares, a 148.34% increase year-over-year.
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 2.61M shares, a 7.55% decline year-over-year.
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 670.00K shares, a 3622.22% increase year-over-year.
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 826.50K shares, a 651.36% increase year-over-year.
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 4.65M shares, a 94.80% increase from fiscal 2024.
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.39M shares, a 23.23% increase from fiscal 2023.
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.94M shares, a 61.16% decline from fiscal 2022.
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 4.99M shares, a 3.63% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 824.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 3.44M shares 10-Q · filed 2026-08-06 | 4.11M shares derived: sum of 3 quarters · filed 2026-08-06 | 4.93M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 2.61M shares 10-Q · filed 2026-05-07 | 3.28M shares derived: sum of 2 quarters · filed 2026-05-07 | 4.11M shares derived: sum of 3 quarters · filed 2026-05-07 | 4.44M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 670.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 1.50M shares derived: sum of 2 quarters · filed 2026-03-16 | 1.83M shares derived: sum of 3 quarters · filed 2026-03-16 | 4.65M shares 10-K · filed 2026-03-16 |
| 2025-09-30 | 826.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 1.16M shares derived: sum of 2 quarters · filed 2025-11-06 | 3.98M shares 10-Q · filed 2025-11-06 | 4.00M shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 332.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 3.16M shares 10-Q · filed 2025-08-07 | 3.18M shares derived: sum of 3 quarters · filed 2025-08-07 | 3.29M shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 2.83M shares 10-Q · filed 2025-05-12 | 2.84M shares derived: sum of 2 quarters · filed 2025-05-12 | 2.95M shares derived: sum of 3 quarters · filed 2025-05-12 | 3.43M shares derived: sum of 4 quarters · filed 2025-05-12 |
| 2024-12-31 | 18.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 128.00K shares derived: sum of 2 quarters · filed 2025-03-06 | 609.00K shares derived: sum of 3 quarters · filed 2025-03-06 | 2.39M shares 10-K · filed 2025-03-06 |
| 2024-09-30 | 110.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 591.00K shares derived: sum of 2 quarters · filed 2024-11-07 | 2.37M shares 10-Q · filed 2024-11-07 | 2.53M shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 481.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 2.26M shares 10-Q · filed 2024-08-08 | 2.42M shares derived: sum of 3 quarters · filed 2024-08-08 | 2.80M shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 1.78M shares 10-Q · filed 2024-05-08 | 1.94M shares derived: sum of 2 quarters · filed 2024-05-08 | 2.32M shares derived: sum of 3 quarters · filed 2024-05-08 | 2.57M shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 159.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | 539.90K shares derived: sum of 2 quarters · filed 2024-03-11 | 787.55K shares derived: sum of 3 quarters · filed 2024-03-11 | 1.94M shares 10-K · filed 2024-03-11 |
| 2023-09-30 | 380.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 628.35K shares derived: sum of 2 quarters · filed 2023-11-07 | 1.78M shares 10-Q · filed 2023-11-07 | 1.81M shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 247.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 1.40M shares 10-Q · filed 2023-08-08 | 1.43M shares derived: sum of 3 quarters · filed 2023-08-08 | 2.97M shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 1.15M shares 10-Q · filed 2023-05-09 | 1.18M shares derived: sum of 2 quarters · filed 2023-05-09 | 2.73M shares derived: sum of 3 quarters · filed 2023-05-09 | 3.59M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 28.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | 1.57M shares derived: sum of 2 quarters · filed 2023-03-27 | 2.43M shares derived: sum of 3 quarters · filed 2023-03-27 | 4.99M shares 10-K · filed 2023-03-27 |
| 2022-09-30 | 1.55M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 2.41M shares derived: sum of 2 quarters · filed 2022-11-08 | 4.96M shares 10-Q · filed 2022-11-08 | 6.03M shares derived: sum of 4 quarters · filed 2023-03-27 |
| 2022-06-30 | 860.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 3.42M shares 10-Q · filed 2022-08-04 | 4.49M shares derived: sum of 3 quarters · filed 2023-03-27 | 4.96M shares derived: sum of 4 quarters · filed 2023-03-27 |
| 2022-03-31 | 2.56M shares 10-Q · filed 2022-05-05 | 3.63M shares derived: sum of 2 quarters · filed 2023-03-27 | 4.10M shares derived: sum of 3 quarters · filed 2023-03-27 | 4.94M shares derived: sum of 4 quarters · filed 2023-03-27 |
| 2021-12-31 | 1.07M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | 1.55M shares derived: sum of 2 quarters · filed 2023-03-27 | 2.39M shares derived: sum of 3 quarters · filed 2023-03-27 | 5.18M shares 10-K/A · filed 2023-03-27 |
| 2021-09-30 | 473.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 1.31M shares derived: sum of 2 quarters · filed 2021-11-04 | 4.11M shares 10-Q · filed 2021-11-04 | 4.56M shares derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | 841.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 3.63M shares 10-Q · filed 2021-08-05 | 4.09M shares derived: sum of 3 quarters · filed 2021-08-05 | 4.54M shares derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | 2.79M shares 10-Q · filed 2021-05-06 | 3.25M shares derived: sum of 2 quarters · filed 2021-05-06 | 3.69M shares derived: sum of 3 quarters · filed 2021-05-06 | 4.21M shares derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | 456.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | 901.90K shares derived: sum of 2 quarters · filed 2021-02-24 | 1.42M shares derived: sum of 3 quarters · filed 2021-02-24 | 4.22M shares 10-K · filed 2021-02-24 |
| 2020-09-30 | 445.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 958.60K shares derived: sum of 2 quarters · filed 2020-11-05 | 3.76M shares 10-Q · filed 2020-11-05 | 4.41M shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 513.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 3.32M shares 10-Q · filed 2020-08-06 | 3.96M shares derived: sum of 3 quarters · filed 2020-08-06 | 4.16M shares derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | 2.80M shares 10-Q · filed 2020-05-07 | 3.45M shares derived: sum of 2 quarters · filed 2020-05-07 | 3.65M shares derived: sum of 3 quarters · filed 2020-05-07 | 3.97M shares derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | 644.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 845.70K shares derived: sum of 2 quarters · filed 2020-02-27 | 1.17M shares derived: sum of 3 quarters · filed 2020-02-27 | 3.27M shares 10-K · filed 2020-02-27 |
| 2019-09-30 | 201.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 521.10K shares derived: sum of 2 quarters · filed 2019-11-07 | 2.62M shares 10-Q · filed 2019-11-07 | 2.83M shares derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-06-30 | 320.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 2.42M shares 10-Q · filed 2019-08-07 | 2.63M shares derived: sum of 3 quarters · filed 2020-02-27 | 2.77M shares derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-03-31 | 2.10M shares 10-Q · filed 2019-05-09 | 2.31M shares derived: sum of 2 quarters · filed 2020-02-27 | 2.45M shares derived: sum of 3 quarters · filed 2020-02-27 | 2.97M shares derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-12-31 | 205.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 350.90K shares derived: sum of 2 quarters · filed 2020-02-27 | 866.00K shares derived: sum of 3 quarters · filed 2020-02-27 | 2.13M shares 10-K · filed 2020-02-27 |
| 2018-09-30 | 145.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 660.50K shares derived: sum of 2 quarters · filed 2018-11-06 | 1.92M shares 10-Q · filed 2018-11-06 | 2.27M shares derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | 515.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 1.78M shares 10-Q · filed 2018-08-08 | 2.13M shares derived: sum of 3 quarters · filed 2020-02-27 | 2.20M shares derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | 1.26M shares 10-Q · filed 2018-05-09 | 1.61M shares derived: sum of 2 quarters · filed 2020-02-27 | 1.69M shares derived: sum of 3 quarters · filed 2020-02-27 | 1.91M shares derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | 352.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 427.35K shares derived: sum of 2 quarters · filed 2020-02-27 | 652.25K shares derived: sum of 3 quarters · filed 2020-02-27 | 2.14M shares 10-K · filed 2020-02-27 |
| 2017-09-30 | 75.15K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | 300.05K shares derived: sum of 2 quarters · filed 2017-11-07 | 1.79M shares 10-Q · filed 2017-11-07 | 1.91M shares derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | 224.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | 1.71M shares 10-Q · filed 2017-08-07 | 1.83M shares derived: sum of 3 quarters · filed 2019-02-27 | 1.89M shares derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | 1.49M shares 10-Q · filed 2017-05-05 | 1.61M shares derived: sum of 2 quarters · filed 2019-02-27 | 1.67M shares derived: sum of 3 quarters · filed 2019-02-27 | 1.94M shares derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | 121.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | 183.20K shares derived: sum of 2 quarters · filed 2019-02-27 | 451.30K shares derived: sum of 3 quarters · filed 2019-02-27 | 1.36M shares 10-K · filed 2019-02-27 |
| 2016-09-30 | 61.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 329.70K shares derived: sum of 2 quarters · filed 2016-11-03 | 1.23M shares 10-Q · filed 2016-11-03 | 1.28M shares derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | 268.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | 1.17M shares 10-Q · filed 2016-08-03 | 1.22M shares derived: sum of 3 quarters · filed 2018-03-07 | |
| 2016-03-31 | 905.25K shares 10-Q · filed 2016-05-06 | 948.58K shares derived: sum of 2 quarters · filed 2018-03-07 | ||
| 2015-12-31 | 43.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 3.31M shares 10-K · filed 2018-03-07 | ||
| 2015-09-30 | 3.27M shares 10-Q · filed 2015-11-23 | |||
| 2014-12-31 | 697.56K shares 10-K · filed 2017-03-02 | |||
| 2013-12-31 | 810.39K shares 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |